Tom Henderson
- Here's the venture capital equivalent of a man-bites-dog story: TransMedics Inc., a medical device company in Andover, Mass., hopes to have approval from the U.S. Food and Drug Adminstration later this year to revolutionize the way organ transplants are done in the U.S. Its device, already approved for use in Europe, keeps organs warm and oxygenated and viable for transplant for two or three days, compared to the low-tech method used now of putting an organ on ice and needing to get it
Tom Henderson
- Here's the venture capital equivalent of a man-bites-dog story: TransMedics Inc., a medical device company in Andover, Mass., hopes to have approval from the U.S. Food and Drug Adminstration later this year to revolutionize the way organ transplants are done in the U.S. Its device, already approved for use in Europe, keeps organs warm and oxygenated and viable for transplant for two or three days, compared to the low-tech method used now of putting an organ on ice and needing to get it